(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. The Cyclin E levels are dynamic during cell cycle transitions; constant
CycE levels halt endocycles and amplification. (A) Wholemount in situ
hybridization indicates equal level of cyclin E mRNA in the follicle
cells throughout oogenesis (arrows). (B,C) Cyclin E antibody staining pattern
(green) between stages 5 (B) and 8 (C) shows a clear downregulation of the
protein after the transition to the endocycle, when cells stop expressing PH3
(red). Cells overexpressing CycE (hsFlp;;UAS-cycE/UASGFP
act<FRT-CD2-FRT<Gal4) express mitotic cyclins B and A past stage 6
in oogenesis (D-E, arrow), have smaller nuclei (F,F') and show highly
reduced BrdU incorporation during endocycling (G,G') and amplification
(H,H') stages, suggesting that cells ectopically expressing cyclin
E fail to undergo S-phase and are halted at G2. Green, CycE (B,C), GFP
(D-F), BrdU (G,H); red, PH3 (B,C), CycB (D), CycA (E), CycE (F-H); blue,
DAPI.